Potentiation of aluminium absorption by effervescent analgesic tablets in a haemodialysis patient.
Main
J
J
Royal Victoria Infirmary, Newcastle upon Tyne.
Ward
M K
MK
D000082:Acetaminophen / Q000009:adverse effects*; D000535:Aluminum / Q000097:blood / Q000493:pharmacokinetics*; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects*; D002951:Citrates / Q000009:adverse effects; D003061:Codeine / Q000009:adverse effects*; D004338:Drug Combinations; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006437:Hemodialysis, Home; D006801:Humans; D007408:Intestinal Absorption; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy*; D008875:Middle Aged; D013607:Tablets
D000700:Analgesics; D002951:Citrates; D004338:Drug Combinations; D013607:Tablets; C526278:acetaminophen, codeine drug combination; D000082:Acetaminophen; D000536:Aluminum Hydroxide; D000535:Aluminum; D003061:Codeine